Takeda Pharmaceutical Company Limited Deferred Tax Liability Asset
Takeda Pharmaceutical Company Limited (TKPHF) had Deferred Tax Liability Asset of -JPY 335.59 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Income Taxes
ifrs-full:DeferredTaxLiabilityAsset · last filed 2025-06-25
- 2025-03-31: Deferred Tax Liability Asset -335.59B JPY.
- 2024-03-31: Deferred Tax Liability Asset -280.09B JPY.
- 2023-03-31: Deferred Tax Liability Asset -95.38B JPY.
- 2022-03-31: Deferred Tax Liability Asset 88.97B JPY.
| Period end | Deferred Tax Liability Asset | Deferred Tax Liability Asset as first filed |
|---|---|---|
| 2025-03-31 | -335.59B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | -280.09B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | -95.38B JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 88.97B JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 189.08B JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | 402.05B JPY 20-F · filed 2022-06-29 | |
| 2019-03-31 | 632.47B JPY 20-F · filed 2021-06-29 | 778.07B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 25.75B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | 34.43B JPY 20-F · filed 2019-06-27 |